Owners, management and financials
CVR: 17558501
Previous names: P.P.H.S.G. 209 A/S, ST. JUDE MEDICAL DANMARK A/S
DKK 198,838,342
Revenue
Net result: DKK 6,225,964
ABBOTT LABORATORIES A/S (100%)
CVR · view owners
Mika Tapio Mustonen
Board: Bradley Jay Slater (chair) and 2 members
CVR · view management
Active
Founded 20 January 1994
CVR · view overview
20 employees
CVR · 2026
Director role ended: Flemming Wærn Johannessen
CVR · 18/04/2024
View the full event history
Abbott Medical Danmark A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 1994. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ST. JUDE MEDICAL DANMARK A/S and P.P.H.S.G. 209 A/S. The management consists of Mika Tapio Mustonen. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Mika Tapio Mustonen. The company is owned by ABBOTT LABORATORIES A/S. The company has 20 employees (2026). In 2025, the company reported revenue of DKK 198,838,342 and a net result of DKK 6,225,964 compared with DKK 7,897,543 the year before. Equity in the 2025 report amounted to DKK 46,327,156.
Source: annual report 2025, Danish Business Authority
Abbott Medical Danmark A/S demonstrates a stable financial health with a slight upward trend in revenue, increasing from 185.8 million DKK in 2023 to 198.8 million DKK in 2025. However, profit has fluctuated, peaking at 7.9 million DKK in 2024 before declining to 6.2 million DKK in 2025. The company's equity position has significantly improved, rising from 121.1 million DKK in 2021 to 46.3 million DKK in 2025, indicating a strong capital base. Despite the recent decline in profit margins, the company remains well-positioned within the medical supply industry, benefiting from consistent revenue generation.
AI-generated summary · Generated 24/06/2026
Selskabets formål er at købe, sælge, handle (hvad enten som agent eller andet), eksportere, importere, vedligeholde, inspicere, afprøve, montere og fremstille medicinske og farmaceutiske produkter samt udvikle, producere og markedsføre teknologi i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser eller assistance, herunder af administrativ, driftsmæssig, finansiel, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selskaber.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 198.8 mio. | 6.2 mio. | 111.3 mio. | 46.3 mio. | 23 | |
| 202401/01/2024 – 31/12/2024 | 192 mio. | 7.9 mio. | 187.6 mio. | 140.1 mio. | 22 | |
| 202301/01/2023 – 31/12/2023 | 185.8 mio. | 7.1 mio. | 177.1 mio. | 132.2 mio. | 23 | |
| 202201/01/2022 – 31/12/2022 | 188.1 mio. | 4 mio. | 173.7 mio. | 125.1 mio. | 24 | |
| 202101/01/2021 – 31/12/2021 | 239.6 mio. | 5.2 mio. | 186.3 mio. | 121.1 mio. | 23 | |
| 202001/01/2020 – 31/12/2020 | 214 mio. | 5.3 mio. | 160.7 mio. | 115.9 mio. | 23 | |
| 201901/01/2019 – 31/12/2019 | 222.3 mio. | 5.7 mio. | 196 mio. | 110.6 mio. | 25 | |
| 201801/01/2018 – 31/12/2018 | 237.6 mio. | 10.2 mio. | 160.5 mio. | 104.9 mio. | 27 | |
| 201701/01/2017 – 31/12/2017 | - | 8.4 mio. | 122.3 mio. | 91.6 mio. | 21 | |
| 201601/01/2016 – 31/12/2016 | - | 5.4 mio. | 125 mio. | 83.2 mio. | 22 | |
| 201501/01/2015 – 31/12/2015 | - | 1.7 mio. | 112.2 mio. | 77.8 mio. | - | |
| 201401/01/2014 – 31/12/2014 | - | 3.6 mio. | 112.4 mio. | 76.1 mio. | 20 | |
| 201301/01/2013 – 31/12/2013 | - | 8.9 mio. | 102.6 mio. | 72.5 mio. | 21 | |
| 201201/01/2012 – 31/12/2012 | - | 7.5 mio. | 87.1 mio. | 63.7 mio. | 20 |
Compared to 293 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
7 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Abbott Medical Danmark A/S is 17558501.
Abbott Medical Danmark A/S is owned by ABBOTT LABORATORIES A/S.
The management of Abbott Medical Danmark A/S consists of Mika Tapio Mustonen.
The board of Abbott Medical Danmark A/S consists of Bradley Jay Slater, Fredrik Björn Anders Björnulfson and Mika Tapio Mustonen, with Bradley Jay Slater as chair.
In 2025, Abbott Medical Danmark A/S reported revenue of DKK 198,838,342.
Abbott Medical Danmark A/S had 20 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Abbott Medical Danmark A/S has published its annual report for 2025. Revenue came to DKK 198,838,342, and the net result was DKK 6,225,964.
Contact info changed: new phone: 44947541 (March 17, 2026).
Abbott Medical Danmark A/S has won the tender "Iskæmi" issued by Region Hovedstaden worth 232,303,118 DKK.
Abbott Medical Danmark A/S has published its annual report for 2024. Revenue came to DKK 191,993,466, and the net result was DKK 7,897,543.
Abbott Medical Danmark A/S has won the tender "TAVI, selvekspanderende" issued by Region Hovedstaden worth 84,660,000 DKK.
Abbott Medical Danmark A/S has won the tender "Udbud af TAVI hjerteklapper" issued by Region Nordjylland worth 4,800 DKK.
Abbott Medical Danmark A/S has won the tender "Udbud af Varer til Spinal Cord Stimulation (SCS)" issued by Region Midtjylland worth 21,600,000 DKK.
Abbott Medical Danmark A/S has won the tender "Udbud af produkter til radiologisk intervention, perifer." issued by Region Nordjylland worth 1 DKK.
Abbott Medical Danmark A/S has won the tender "Udbud af Strukturelt Hjerte" issued by Region Hovedstaden worth 72,710,277 DKK.
Abbott Medical Danmark A/S has won the tender "Udbud af kardiologiske stent mv." issued by Region Nordjylland worth 42,104,368 DKK.
Abbott Medical Danmark A/S has published its annual report for 2023. Revenue came to DKK 185,830,596, and the net result was DKK 7,060,135.
As of April 18, 2024, Mika Tapio Mustonen has joined the board of directors of Abbott Medical Danmark A/S.
As of April 18, 2024, Flemming Wærn Johannessen has left the board of directors of Abbott Medical Danmark A/S.
As of April 18, 2024, Mika Tapio Mustonen is registered as director of Abbott Medical Danmark A/S.
As of April 18, 2024, Flemming Wærn Johannessen has stepped down as director of Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S has published its annual report for 2022. Revenue came to DKK 188,118,000, and the net result was DKK 4,050,000.
As of September 1, 2022, Bradley Jay Slater has joined the board of directors of Abbott Medical Danmark A/S.
As of September 1, 2022, Benjamin Edward Oosterbaan has left the board of directors of Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S has published its annual report for 2021. Revenue came to DKK 239,642,278, and the net result was DKK 5,232,757.
Abbott Medical Danmark A/S has published its annual report for 2020. Revenue came to DKK 213,955,074, and the net result was DKK 5,265,414.
Abbott Medical Danmark A/S has published its annual report for 2019. Revenue came to DKK 222,315,485, and the net result was DKK 5,674,173.
Abbott Medical Danmark A/S has published its annual report for 2018. Revenue came to DKK 237,631,789, and the net result was DKK 10,222,857.
As of January 22, 2019, Flemming Wærn Johannessen has joined the board of directors of Abbott Medical Danmark A/S.
As of January 22, 2019, Benjamin Edward Oosterbaan has joined the board of directors of Abbott Medical Danmark A/S.
As of January 22, 2019, Brian B. Yoor has left the board of directors of Abbott Medical Danmark A/S.
As of January 21, 2019, Benjamin Edward Oosterbaan has left the board of directors of Abbott Medical Danmark A/S.
As of November 1, 2018, ABBOTT LABORATORIES A/S is registered as an owner of Abbott Medical Danmark A/S with an ownership share of 100%.
Abbott Medical Danmark A/S has published its annual report for 2017. Gross profit came to DKK 32,263,351, and the net result was DKK 8,445,172.
On December 1, 2017, the company changed its name from ST. JUDE MEDICAL DANMARK A/S to Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S has published its annual report for 2016. Gross profit came to DKK 28,339,844, and the net result was DKK 5,365,148.
As of January 5, 2017, Fredrik Björn Anders Björnulfson has joined the board of directors of Abbott Medical Danmark A/S.
As of January 5, 2017, Brian B. Yoor has joined the board of directors of Abbott Medical Danmark A/S.
As of January 5, 2017, Benjamin Edward Oosterbaan has joined the board of directors of Abbott Medical Danmark A/S.
As of January 5, 2017, Tyge Jesper Rothe has left the board of directors of Abbott Medical Danmark A/S.
As of January 5, 2017, Dodd Joseph Gray has left the board of directors of Abbott Medical Danmark A/S.
As of January 5, 2017, Kashif Rashid has left the board of directors of Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S has published its annual report for 2015. The net result was DKK 1,691,998.
As of May 11, 2016, Kashif Rashid has joined the board of directors of Abbott Medical Danmark A/S.
As of May 11, 2016, Jason Ashley Zellers has left the board of directors of Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S has published its annual report for 2014. Gross profit came to DKK 25,554,344, and the net result was DKK 3,558,793.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Abbott Medical Danmark A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S has published its annual report for 2013. Gross profit came to DKK 35,595,751, and the net result was DKK 8,897,151.
Abbott Medical Danmark A/S has published its annual report for 2012. Gross profit came to DKK 31,012,413, and the net result was DKK 7,469,387.
As of December 7, 2012, Dodd Joseph Gray has joined the board of directors of Abbott Medical Danmark A/S.
As of December 7, 2012, Willem Jozef Jean Eeraerts has left the board of directors of Abbott Medical Danmark A/S.
As of December 31, 2011, Jason Ashley Zellers has joined the board of directors of Abbott Medical Danmark A/S.
As of December 31, 2011, Pamela Sue Krop has left the board of directors of Abbott Medical Danmark A/S.
As of August 10, 2010, JUT NR. 2180 A/S has been appointed auditor of Abbott Medical Danmark A/S.
As of August 10, 2010, EY Danmark A/S has stepped down as auditor of Abbott Medical Danmark A/S.
As of June 30, 2007, Willem Jozef Jean Eeraerts has joined the board of directors of Abbott Medical Danmark A/S.
As of June 30, 2007, Michel Victor Hestor Cavadini has left the board of directors of Abbott Medical Danmark A/S.
As of January 1, 2007, Flemming Wærn Johannessen is registered as director of Abbott Medical Danmark A/S.
As of January 1, 2007, Ulf Arendt Bertilsson Grape has stepped down as director of Abbott Medical Danmark A/S.
As of July 1, 2006, Pamela Sue Krop has joined the board of directors of Abbott Medical Danmark A/S.
As of July 1, 2006, Kevin O'Malley has left the board of directors of Abbott Medical Danmark A/S.
As of January 2, 2003, Ulf Arendt Bertilsson Grape is registered as director of Abbott Medical Danmark A/S.
As of January 2, 2003, Svend Erik Volfram Hansen has stepped down as director of Abbott Medical Danmark A/S.
As of August 28, 1997, Kevin O'Malley has joined the board of directors of Abbott Medical Danmark A/S.
As of August 28, 1997, Claude Arthur Marie Van Droogenbroeck has left the board of directors of Abbott Medical Danmark A/S.
As of August 28, 1997, Diane Marion Johnson has left the board of directors of Abbott Medical Danmark A/S.
As of August 28, 1997, Svend Erik Volfram Hansen is registered as director of Abbott Medical Danmark A/S.
As of August 28, 1997, Tyge Jesper Rothe has stepped down as director of Abbott Medical Danmark A/S.
As of June 26, 1997, Tyge Jesper Rothe is registered as director of Abbott Medical Danmark A/S.
As of June 26, 1997, Claude Arthur Marie Van Droogenbroeck has stepped down as director of Abbott Medical Danmark A/S.
As of May 11, 1995, Diane Marion Johnson has joined the board of directors of Abbott Medical Danmark A/S.
As of May 11, 1995, Todd Frederik Davenport has left the board of directors of Abbott Medical Danmark A/S.
As of September 26, 1994, CJ Partnership I/S has stepped down as auditor of Abbott Medical Danmark A/S.
On August 25, 1994, the company changed its name from P.P.H.S.G. 209 A/S to ST. JUDE MEDICAL DANMARK A/S.
As of August 24, 1994, Henning Hansen has left the board of directors of Abbott Medical Danmark A/S.
As of August 24, 1994, Mogens Gaarden has left the board of directors of Abbott Medical Danmark A/S.
As of August 24, 1994, Henning Hansen has stepped down as director of Abbott Medical Danmark A/S.
As of January 20, 1994, EY Danmark A/S has been appointed auditor of Abbott Medical Danmark A/S.
As of January 20, 1994, CJ Partnership I/S has been appointed auditor of Abbott Medical Danmark A/S.
As of January 20, 1994, Henning Hansen has joined the board of directors of Abbott Medical Danmark A/S.
As of January 20, 1994, Mogens Gaarden has joined the board of directors of Abbott Medical Danmark A/S.
As of January 20, 1994, Tyge Jesper Rothe has joined the board of directors of Abbott Medical Danmark A/S.
As of January 20, 1994, Claude Arthur Marie Van Droogenbroeck has joined the board of directors of Abbott Medical Danmark A/S.
As of January 20, 1994, Todd Frederik Davenport has joined the board of directors of Abbott Medical Danmark A/S.
As of January 20, 1994, Michel Victor Hestor Cavadini has joined the board of directors of Abbott Medical Danmark A/S.
As of January 20, 1994, Henning Hansen is registered as director of Abbott Medical Danmark A/S.
As of January 20, 1994, Claude Arthur Marie Van Droogenbroeck is registered as director of Abbott Medical Danmark A/S.
Abbott Medical Danmark A/S was founded on January 20, 1994.
Companies in the same industry and area
CVR 45320618
CVR 13902992
CVR 27478700
CVR 51619811
CVR 45224260
